Eurofins Scientific Announces the Acquisition of Quasfar, Establishing a Presence in Colombia and Expanding the Presence of Eurofins Laboratories in Latin America
2023年11月16日 - 10:42PM
ビジネスワイヤ(英語)
The Eurofins network of companies, the global leader in food,
environment, pharmaceutical and cosmetic product testing and in
discovery pharmacology, forensics, advanced material sciences and
agroscience contract research services, announces the completion of
the acquisition of Quasfar.
Known as Eurofins Quasfar going forward, the laboratory
represents the first Eurofins laboratory in Colombia and is a
leading pharmaceutical, veterinary and cosmetic product testing
laboratory, with over 26 years of experience, employing over 100
employees. Based in Bogotá, Colombia, the 1,680 m² laboratory is
equipped with state-of-the-art testing equipment, technology and
information platforms and systems, and is certified in Good
Laboratory Practices for pharmaceutical quality control
laboratories, under the guidelines of WHO Technical Report Series,
No. 957, 2010 44th Report – Annex 1. With a focus on scientific
training and R&D, the Quasfar team develops analytical
methodologies that respond to customer and regulatory needs, with a
commitment to exceptional quality management systems, and good
laboratory, bioavailability and bioequivalence practices.
The origins of Eurofins’ presence in Brazil dates back to 2001,
when Eurofins Genescan established its presence in Brazil, setting
up an office in São Paulo/SP, shortly followed by the opening of a
laboratory. Since then, the Eurofins network of companies has
continued to expand in Brazil and Latin America, with more than 10
laboratories across 5 LATAM countries now operating across food,
environmental, pharmaceutical, agroscience, and clinical
diagnostics testing, as well as providing special consultancy
services and audits.
With a proven history in providing support to the pharmaceutical
sector in Colombia, the acquisition of Quasfar strengthens the
Eurofins network’s support to the pharmaceutical industry in Latin
America, through the provision of R&D and supporting evaluation
in the early stages of pharmaceutical product development, with the
highest quality standards and TAT.
Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With over 61,000 staff across a
network of ca. 900 laboratories in 61 countries, Eurofins offers a
portfolio of over 200,000 analytical methods.
Eurofins Shares are listed on Euronext Paris Stock Exchange.
Eurofins Quasfar: Bogotá- based Eurofins Quasfar is a
state-of-the-art laboratory, offering a broad analytical testing
portfolio to the pharmaceutical, veterinary and cosmetic segments,
and recognised for its expertise in developing complex analytical
methodologies with diverse techniques to meet customer and
regulatory needs.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231116556347/en/
Further information: edbr-marketing@eurofinslatam.com
Enerplus (NYSE:ERF)
過去 株価チャート
から 4 2024 まで 5 2024
Enerplus (NYSE:ERF)
過去 株価チャート
から 5 2023 まで 5 2024